Loading organizations...
§ Venture Capital · Singapore
Pharmaceutical manufacturer developing plant-based nutraceuticals & drugs from Ayurveda for human & animal health.
Bioved Pharmaceuticals develops and commercializes plant-based products, utilizing a proprietary discovery platform for nutraceuticals and over-the-counter solutions. The company specializes in isolating bioactive fractions from botanicals using patented processes to create scientifically validated formulations. This approach underpins their focus on effective plant-based medicines and health supplements.
Dr. Deepa Chitre, holding medical degrees from the University of California San Francisco and Grant Medical College, founded Bioved Pharmaceuticals in 1999. Her founding insight emerged from observing significant improvement in her dog, Bandu, after administering an early joint health supplement prototype. This experience catalyzed the company’s dedication to harnessing the therapeutic potential of natural ingredients.
Bioved Pharmaceuticals serves global pharmaceutical, biotech, and nutraceutical partners. The company aims to provide safe and effective plant-based solutions, driven by a vision to contribute to healthier lives through natural product innovation and scientific validation. They continue to explore and expand applications for their botanical extracts.
Bioved Ventures has 1 tracked investment across 1 company. The latest tracked deal is $8.0M Series B in Sensely in February 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 14, 2017 | Sensely | $8.0M Series B | Richard GU | Fenox Venture Capital, Mayo Clinic, Stanford |